CN106620815A - Gel dressing based on G-quadruplex/collagen, as well as preparation and application of gel dressing - Google Patents
Gel dressing based on G-quadruplex/collagen, as well as preparation and application of gel dressing Download PDFInfo
- Publication number
- CN106620815A CN106620815A CN201611038109.XA CN201611038109A CN106620815A CN 106620815 A CN106620815 A CN 106620815A CN 201611038109 A CN201611038109 A CN 201611038109A CN 106620815 A CN106620815 A CN 106620815A
- Authority
- CN
- China
- Prior art keywords
- collagen
- quadruplex
- gel dressing
- preparation
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
本发明公开了一种基于G‑四联体/胶原蛋白的凝胶敷料及其制备方法,将鸟嘌呤核苷、硼酸与氢氧化钾按照1~3:1:1加入去离子水中,加热到90~98℃,得到G‑四联体溶液;冷却到35~40℃,加入胶原蛋白使其分散,使胶原蛋白在溶液中的浓度为2~10mg/mL,冷却到室温,得到所述基于G‑四联体/胶原蛋白的凝胶敷料。所述制备方法反应条件简单,合成步骤少,耗时短,生产成本低。所述凝胶敷料用于伤口愈合显示生物相容性好,透气性好,黏附性强,含水量高,维持湿润的环境,使伤口不易结痂。本发明所述凝胶敷料不含任何刺激性成分,无毒副作用。所述凝胶敷料用于加速伤口愈合,具有潜在的应用价值。
The invention discloses a gel dressing based on G-quadruplex/collagen and a preparation method thereof. Guanine nucleoside, boric acid and potassium hydroxide are added into deionized water at a ratio of 1 to 3:1:1, and heated to 90-98°C to obtain G-quadruplex solution; cool to 35-40°C, add collagen to disperse it so that the concentration of collagen in the solution is 2-10 mg/mL, and cool to room temperature to obtain the G‑tetrad/collagen gel dressing. The preparation method has simple reaction conditions, few synthesis steps, short time consumption and low production cost. When the gel dressing is used for wound healing, it has good biocompatibility, good air permeability, strong adhesion, high water content, maintains a humid environment, and makes the wound difficult to scab. The gel dressing of the invention does not contain any irritating ingredients and has no toxic and side effects. The gel dressing is used to accelerate wound healing and has potential application value.
Description
技术领域technical field
本发明属于医用敷料领域,涉及一种凝胶敷料及其制备方法,特别是涉及一种可促进伤口愈合基于G-四联体/胶原蛋白的凝胶敷料及其制备方法。The invention belongs to the field of medical dressings, and relates to a gel dressing and a preparation method thereof, in particular to a G-quadruplex/collagen-based gel dressing capable of promoting wound healing and a preparation method thereof.
背景技术Background technique
伤口是正常皮肤在外界因素如外科手术、热、外力、电流、低温等作用下所造成的损伤。若处理不及时,伤口可能会感染,或者进一步恶化。传统上常使用的敷料是纱布、棉料等材料,但是这些敷料在止血、保湿、防止伤口感染和促进伤口愈合等方面的效果差强人意。Wound is the damage of normal skin caused by external factors such as surgery, heat, external force, electric current, low temperature, etc. If left untreated, the wound may become infected or worsen. Traditionally used dressings are gauze, cotton and other materials, but the effects of these dressings on hemostasis, moisturizing, preventing wound infection and promoting wound healing are not satisfactory.
胶原蛋白是动物结缔组织的主要成分,也是哺乳动物体内含量最多的功能性蛋白。由于其低免疫原性、降解性、生物相容性及凝血性等特性,胶原蛋白已被广泛地作为生物材料。相较于其它的伤口敷料,含胶原蛋白的凝胶敷料制备简便、耗时短和生物活性好,对伤口愈合具有良好效果。Collagen is the main component of animal connective tissue and the most abundant functional protein in mammals. Collagen has been widely used as a biomaterial due to its low immunogenicity, degradability, biocompatibility, and coagulation properties. Compared with other wound dressings, the collagen-containing gel dressing is easy to prepare, takes a short time, has good biological activity, and has a good effect on wound healing.
已存在的凝胶敷料主要还存在以下几个问题:I.制备方面,凝胶的合成还存在制备复杂、耗时长等不足。II.性能方面,凝胶机械强度较差且具有一定的生物毒性。III伤口愈合方面,部分敷料存在透气性差及伤口愈合时间长。因此,制备出简便、有效的凝胶敷料用于伤口的快速愈合,将具有重要的研究意义和应用价值。The existing gel dressing mainly also has the following problems: 1. In terms of preparation, the synthesis of the gel also has deficiencies such as complicated preparation and long time consumption. II. In terms of performance, the gel has poor mechanical strength and has certain biological toxicity. III In terms of wound healing, some dressings have poor air permeability and long wound healing time. Therefore, preparing a simple and effective gel dressing for rapid wound healing will have important research significance and application value.
发明内容Contents of the invention
针对现有技术的上述不足,本发明的目的在于解决了凝胶敷料的制备繁杂问题,克服了凝胶敷料透气性差、愈合时间长、生物相容性差的不足;选用可降解的、生物相容性好的G-四联体和胶原蛋白作为原料,制备得到的基于G-四联体/胶原蛋白的凝胶敷料具有良好的机械性能,保持对伤口的保湿、黏附并避免感染,有效地、快速地促进伤口的愈合。Aiming at the above-mentioned deficiencies of the prior art, the object of the present invention is to solve the complicated problem of preparation of the gel dressing, overcome the deficiencies of the gel dressing such as poor air permeability, long healing time, and poor biocompatibility; select degradable, biocompatible Using G-quadruplex and collagen as raw materials, the prepared G-quadruplex/collagen-based gel dressing has good mechanical properties, keeps the wound moisturized, adheres and avoids infection, effectively, Promotes rapid wound healing.
本发明制备可促进伤口愈合的G-四联体/胶原蛋白的凝胶敷料的反应机理如图1所示:The present invention prepares the reaction mechanism of the G-quadruplex/collagen gel dressing that can promote wound healing as shown in Figure 1:
鸟嘌呤核苷与邻近的鸟嘌呤核苷因为氢键的作用结合在一起,这样相连的四个鸟嘌呤核苷与一个K+配位,形成G-四联体;G-四联体之间通过硼酸根桥连在一起,形成空间网状结构。当加入胶原蛋白时,胶原蛋白会嵌入其中,最终形成基于G-四联体/胶原蛋白的凝胶。Guanine nucleosides are combined with adjacent guanosine nucleosides due to hydrogen bonds, and the four connected guanosine nucleosides coordinate with a K+ to form a G-quadruplex; G-quadruplexes are connected by The borate groups are bridged together to form a spatial network. When collagen is added, the collagen becomes embedded in it, eventually forming a G-quadruplex/collagen based gel.
根据上述原理,本发明采用如下的技术方案:According to above-mentioned principle, the present invention adopts following technical scheme:
一种基于G-四联体/胶原蛋白的凝胶敷料的制备方法,包括以下步骤:A preparation method based on G-quadruplex/collagen gel dressing, comprising the following steps:
(1)将鸟嘌呤核苷、硼酸与氢氧化钾加入水中,加热,待鸟嘌呤核苷完全溶解,得到G-四联体溶液;(1) Add guanosine, boric acid and potassium hydroxide into water, heat, and wait for the guanosine to be completely dissolved to obtain a G-quadruplex solution;
(2)待步骤(1)中的G-四联体溶液冷却后,加入胶原蛋白,使胶原蛋白分散,得到所述基于G-四联体/胶原蛋白的凝胶敷料。(2) After cooling the G-quadruplex solution in step (1), add collagen to disperse the collagen to obtain the G-quadruplex/collagen-based gel dressing.
其中,所述步骤(1)中,Wherein, in the step (1),
所述鸟嘌呤核苷还可以用腺嘌呤核苷、胞嘧啶核苷替代。The guanosine can also be replaced by adenosine and cytosine.
所述氢氧化钾还可以用氢氧化钠、氢氧化锂替代。Described potassium hydroxide can also be replaced with sodium hydroxide, lithium hydroxide.
所述鸟嘌呤核苷、硼酸与氢氧化钾的摩尔比为1~3:1:1;优选地为,2:1:1。The molar ratio of guanosine, boric acid and potassium hydroxide is 1-3:1:1; preferably, 2:1:1.
所述水为去离子水。The water is deionized water.
所述加热的温度为90~98℃;优选地为95℃。The heating temperature is 90-98°C; preferably 95°C.
所述加热的时间为15-25;优选地为15-20分钟。The heating time is 15-25 minutes; preferably 15-20 minutes.
其中,所述步骤(2)中,Wherein, in the step (2),
所述冷却的温度为35~40℃。The cooling temperature is 35-40°C.
所述胶原蛋白可以来自但不限于罗非鱼鱼皮、鳕鱼鱼皮。The collagen can be from but not limited to tilapia skin, cod skin.
所述胶原蛋白分散后的浓度为2~10mg/mL;优选地为5mg/mL。The concentration of the dispersed collagen is 2-10 mg/mL; preferably 5 mg/mL.
具体地,所述步骤包括:Specifically, the steps include:
(1)将鸟嘌呤核苷、硼酸与氢氧化钾按照1~3:1:1的摩尔比加入到去离子水中,震荡5~10分钟,水浴加热到90~98℃,保持恒温15~25分钟,待鸟嘌呤核苷完全溶解,得到G-四联体。(1) Add guanosine, boric acid and potassium hydroxide into deionized water at a molar ratio of 1 to 3:1:1, shake for 5 to 10 minutes, heat the water bath to 90 to 98°C, and keep a constant temperature of 15 to 25 Minutes, until the guanosine is completely dissolved, and the G-quadruplex is obtained.
(2)将上述步骤(1)的溶液缓慢冷却到35~40℃之间,水浴保持恒温,加入胶原蛋白,使胶原蛋白在溶液中的浓度为2~10mg/mL,摇晃使其迅速分散,冷却到室温,制得基于G-四联体/胶原蛋白的凝胶敷料。(2) Slowly cool the solution in the above step (1) to 35-40°C, keep the water bath at a constant temperature, add collagen so that the concentration of collagen in the solution is 2-10mg/mL, shake it to disperse quickly, After cooling to room temperature, a G-quartet/collagen based gel dressing was prepared.
其中,步骤(1)中,在加入鸟嘌呤核苷后,先加入硼酸,再加入氢氧化钾,且加入硼酸或氢氧化钾后,迅速摇晃20s,这样有助于鸟嘌呤核苷的溶解。Wherein, in step (1), after adding guanosine, first add boric acid, then add potassium hydroxide, and after adding boric acid or potassium hydroxide, shake rapidly for 20 seconds, which helps the dissolution of guanosine.
其中,步骤(1)中,鸟嘌呤核苷、硼酸与氢氧化钾的摩尔比为2:1:1,水浴加热温度为95℃反应条件最佳;上述步骤(2)中的胶原蛋白的浓度为5mg/mL时敷料效果最佳。Wherein, in step (1), the molar ratio of guanosine, boric acid and potassium hydroxide is 2:1:1, and the water bath heating temperature is 95° C. The reaction conditions are the best; the concentration of collagen in the above step (2) The best dressing effect is 5mg/mL.
本发明还提出了由上述制备方法制备得到的基于G-四联体/胶原蛋白的凝胶敷料。The present invention also proposes the gel dressing based on G-quadruplex/collagen prepared by the above preparation method.
本发明的基于G-四联体/胶原蛋白的凝胶敷料组成简单、制备方便,透气性能好,黏附性强,机械性能好,生物相容性好。The G-tetrad/collagen-based gel dressing of the present invention has simple composition, convenient preparation, good air permeability, strong adhesion, good mechanical properties and good biocompatibility.
本发明还提出了所述基于G-四联体/胶原蛋白的凝胶敷料在促进伤口处细胞的增殖、分化中的应用。The present invention also proposes the application of the gel dressing based on G-quadruplex/collagen in promoting the proliferation and differentiation of cells in wounds.
本发明还提出了所述基于G-四联体/胶原蛋白的凝胶敷料在制备促进伤口愈合的产品中的应用。The present invention also proposes the application of the G-quadruplex/collagen-based gel dressing in the preparation of products for promoting wound healing.
本发明中,所述基于G-四联体/胶原蛋白的凝胶敷料可以作为一种生物材料。In the present invention, the G-quadruplex/collagen-based gel dressing can be used as a biomaterial.
本发明中,所述基于G-四联体/胶原蛋白的凝胶敷料可以加速伤口的愈合。In the present invention, the G-quadruplex/collagen-based gel dressing can accelerate wound healing.
本发明中,所述基于G-四联体/胶原蛋白的凝胶敷料用于小鼠伤口愈合,具有如下特征:①止血快,吸收组织分泌液,增强在伤口的黏附力;②维持伤口相对湿润的环境,降低感染机率;③加速细胞增殖、分化,促进皮肤的再生。In the present invention, the gel dressing based on G-quadruplex/collagen is used for wound healing in mice, and has the following characteristics: 1. fast hemostasis, absorption of tissue secretions, and enhanced adhesion in the wound; 2. maintenance of wound relative A humid environment reduces the chance of infection; ③ accelerates cell proliferation and differentiation, and promotes skin regeneration.
本发明中,所述基于G-四联体/胶原蛋白的凝胶敷料,包括但不限于作为伤口敷料。In the present invention, the G-quadruplex/collagen-based gel dressing includes, but is not limited to, a wound dressing.
本发明中,所述基于G-四联体/胶原蛋白的凝胶敷料,包括但不限于用于小鼠伤口的愈合。In the present invention, the G-quadruplex/collagen-based gel dressing includes, but is not limited to, used for wound healing in mice.
本发明中,所述基于G四联体/胶原蛋白的凝胶敷料,包括但不限于用于药物的负载。In the present invention, the G-quartet/collagen-based gel dressing includes, but is not limited to, the loading of drugs.
本发明所提供的基于G-四联体/胶原蛋白的凝胶敷料的制备方法,反应条件简单,合成步骤少,耗时短,生产成本低。本发明所提供的基于G-四联体/胶原蛋白凝胶敷料用于伤口愈合,具有生物相容性好、透气性好、黏附性强、含水量高的优点,维持伤口湿润的环境,使伤口不易结痂。本发明所述的基于G-四联体/胶原蛋白的凝胶敷料不含任何刺激性成分,无毒副作用。本发明所提供的基于G-四联体/胶原蛋白的凝胶敷料用于加速伤口愈合,具有潜在的应用价值。The preparation method of the G-quadruplex/collagen-based gel dressing provided by the invention has simple reaction conditions, few synthesis steps, short time consumption and low production cost. The G-quadruplex/collagen gel dressing provided by the present invention is used for wound healing, has the advantages of good biocompatibility, good air permeability, strong adhesion, and high water content, and maintains a moist environment for the wound, enabling The wound is not easy to scab. The G-quadruplex/collagen-based gel dressing of the present invention does not contain any irritating ingredients and has no toxic and side effects. The G-quadruplex/collagen-based gel dressing provided by the invention is used for accelerating wound healing and has potential application value.
附图说明Description of drawings
图1是本发明制备基于G-四联体/胶原蛋白的凝胶敷料的反应机理图。Fig. 1 is a diagram showing the reaction mechanism of the present invention to prepare G-quadruplex/collagen-based gel dressing.
图2是实施例2中制备的凝胶。Figure 2 is the gel prepared in Example 2.
图3是对照组、治疗组(实施例2中制备的凝胶)伤口在第0、3、5、7天的愈合情况。Fig. 3 is the healing situation of the wounds of the control group and the treatment group (gel prepared in Example 2) on days 0, 3, 5, and 7.
图4是对照组、治疗组(实施例2中制备的凝胶)在第0、3、5、7天的伤口面积差异。Fig. 4 shows the differences in wound area between the control group and the treatment group (gel prepared in Example 2) on days 0, 3, 5, and 7.
图5是对照组、治疗组(实施例2中制备的凝胶)在第3、5、7天的组织学情况。Fig. 5 is the histological situation of the control group and the treatment group (the gel prepared in Example 2) on the 3rd, 5th and 7th day.
图6是对照组、治疗组(实施例2中制备的凝胶)的细胞毒性实验。Fig. 6 is the cytotoxicity experiment of the control group and the treatment group (the gel prepared in Example 2).
具体实施方式detailed description
结合以下具体实施例和附图,对本发明作进一步的详细说明。实施本发明的过程、条件、实验方法等,除以下专门提及的内容之外,均为本领域的普遍知识和公知常识,本发明没有特别限制内容。The present invention will be further described in detail in conjunction with the following specific embodiments and accompanying drawings. The process, conditions, experimental methods, etc. for implementing the present invention, except for the content specifically mentioned below, are common knowledge and common knowledge in this field, and the present invention has no special limitation content.
实施例1Example 1
(1)将鸟嘌呤核苷、硼酸与氢氧化钾按照1:1:1的摩尔比加入到去离子水中,震荡5分钟,水浴加热到90℃,恒温20分钟,待鸟嘌呤核苷完全溶解。(1) Add guanosine, boric acid and potassium hydroxide into deionized water at a molar ratio of 1:1:1, shake for 5 minutes, heat the water bath to 90°C, and keep the temperature for 20 minutes until the guanosine is completely dissolved .
(2)将上述溶液缓慢冷却到37℃,水浴保持恒温,加入胶原蛋白,使胶原蛋白在溶液中的浓度为5mg/mL,摇晃使其迅速分散,冷却到室温,制得基于G-四联体/胶原蛋白的凝胶敷料。(2) Slowly cool the above solution to 37°C, keep the water bath at a constant temperature, add collagen so that the concentration of collagen in the solution is 5 mg/mL, shake it to disperse it quickly, and cool it to room temperature to obtain a G-quadruple body/collagen gel dressing.
实施例2Example 2
(1)将鸟嘌呤核苷、硼酸与氢氧化钾按照2:1:1的摩尔比加入到去离子水中,震荡10分钟,水浴加热到95℃,保持恒温15分钟,待鸟嘌呤核苷完全溶解。(1) Add guanosine, boric acid and potassium hydroxide into deionized water at a molar ratio of 2:1:1, shake for 10 minutes, heat the water bath to 95°C, and keep the constant temperature for 15 minutes until the guanosine is completely dissolve.
(2)将上述的溶液缓慢冷却到40℃之间,水浴保持恒温,加入胶原蛋白,使胶原蛋白在溶液中的浓度为7mg/mL,摇晃使其迅速分散,冷却到室温,制得基于G-四联体/胶原蛋白的凝胶敷料。制备的凝胶见图2所示。将制备好的凝胶倒立放置时,凝胶会粘在瓶壁上,不像水溶液会流下去;且经过15天后,凝胶倒立放置仍会粘在瓶壁上。这说明了基于G-四联体/胶原蛋白的凝胶敷料具有良好的机械性能。(2) Slowly cool the above solution to 40°C, keep the water bath at a constant temperature, add collagen to make the concentration of collagen in the solution 7mg/mL, shake it to make it disperse quickly, cool to room temperature, and prepare the product based on G - Gel dressing of tetrad/collagen. The prepared gel is shown in Figure 2. When the prepared gel is placed upside down, the gel will stick to the bottle wall, unlike the aqueous solution that will flow down; and after 15 days, the gel will still stick to the bottle wall when placed upside down. This illustrates the good mechanical properties of the G-tetrad/collagen based gel dressing.
实施例3:Example 3:
以实验例2中制备的凝胶用于小鼠伤口的愈合,作为治疗组。The gel prepared in Experimental Example 2 was used for wound healing of mice as a treatment group.
本实验采用手术方法在ICR小鼠背部制作创伤性疤痕模型。通过在创伤表面涂抹凝胶,每天观察表面疤痕平复情况,评价产品对疤痕的修复功效。In this experiment, a traumatic scar model was made on the back of ICR mice by surgical method. By applying the gel on the surface of the wound, observe the healing of the surface scars every day, and evaluate the repairing effect of the product on the scars.
(1)造模(1) modeling
在1%戊巴比妥钠5mL/kg腹腔注射麻醉下,对小鼠背部进行剪毛,用4%硫化钠脱毛,平行脊椎两侧分别作直径约为1.5cm的圆形切口。如轻微出血则以无菌棉球擦拭止血后,送回鼠盒中。Under anesthesia by intraperitoneal injection of 1% pentobarbital sodium 5mL/kg, the back of the mouse was sheared, depilated with 4% sodium sulfide, and a circular incision with a diameter of about 1.5 cm was made on both sides of the parallel spine. If there is slight bleeding, wipe the mouse with a sterile cotton ball to stop the bleeding, and return it to the mouse box.
(2)动物分组(2) Animal grouping
将造模成功的ICR小鼠随机分为a、b、c组,每组3只。The successfully modeled ICR mice were randomly divided into groups a, b, and c, with 3 mice in each group.
A对照组:将小鼠右侧的伤口作为对照组。A control group: the wound on the right side of the mouse was used as the control group.
B治疗组:将小鼠左侧的伤口作为治疗组。B treatment group: the wound on the left side of the mice was used as the treatment group.
对照组不做任何处理,让其正常愈合。将凝胶敷料涂抹在治疗组创面上,每天涂抹一次,每天观察表面疤痕修复情况。当实验进行至第3天时,对a组小鼠进行处理,将伤口制作成切片,用于组织学表征,观察伤口表层细胞的生长情况。当实验进行至第5天时,对b组小鼠进行处理,将伤口制作成切片,用于组织学表征,观察伤口表层细胞的生长情况。当实验进行至第7天时,对c组小鼠进行处理,将伤口制作成切片,用于组织学表征,观察伤口表层细胞的生长情况。The control group was allowed to heal normally without any treatment. The gel dressing was applied to the wounds of the treatment group once a day, and the surface scar repair was observed every day. When the experiment was carried out to the third day, the mice in group a were treated, and the wounds were sliced for histological characterization, and the growth of wound surface cells was observed. When the experiment was carried out to the fifth day, the mice in group b were treated, and the wounds were sliced for histological characterization, and the growth of wound surface cells was observed. When the experiment was carried out to the 7th day, the mice in group c were treated, and the wounds were sliced for histological characterization, and the growth of wound surface cells was observed.
(3)结果(3) Results
如图3所示,将凝胶敷料涂抹到小鼠伤口,敷料会黏附在伤口上,不会像液体脱落,这说明敷料较强的粘附性;经过4h后,敷料会风干,说明透气性好。手术第3天时,小鼠伤口发生一定的收缩及结痂现象,但是明显可以观察对照组与治疗组小鼠伤口的愈合有明显的区别。由于,对治疗组进行凝胶敷料涂抹治疗的疤痕愈合速率明显好于对照组。到第7天,治疗组小鼠伤口面积极小,基本愈合完全,恢复效果好。As shown in Figure 3, when the gel dressing is applied to the mouse wound, the dressing will adhere to the wound and will not fall off like a liquid, which shows that the dressing has strong adhesion; after 4 hours, the dressing will dry, which shows the air permeability it is good. On the 3rd day after the operation, the mouse wounds contracted and scabbed to a certain extent, but it was obvious that there was a significant difference in the wound healing between the control group and the treatment group. Because, the scar healing rate of the gel dressing smear treatment to the treatment group is significantly better than that of the control group. By the 7th day, the wound area of the mice in the treatment group was extremely small, basically healed completely, and the recovery effect was good.
如图4所示,通过对照组、治疗组伤口面积在不同时间段的比较,明显观察到治疗组的伤口愈合速率远胜于对照组,说明基于G-四联体/胶原蛋白的凝胶敷料用于伤口愈合具有良好的效果。As shown in Figure 4, through the comparison of the wound area of the control group and the treatment group at different time periods, it was clearly observed that the wound healing rate of the treatment group was far better than that of the control group, indicating that the gel dressing based on G-quadruplex/collagen Good for wound healing.
如图5所示,由于对治疗组进行了凝胶敷料的涂抹,胶原蛋白促进了伤口处细胞的增殖、分化。从组织学观察到治疗组的细胞上皮化程度优于对照组,促使治疗组小鼠皮肤的再生明显快于对照组。到第7天,治疗组小鼠皮肤基本上已经再生完全。As shown in Figure 5, since the gel dressing was applied to the treatment group, collagen promoted the proliferation and differentiation of cells in the wound. From the histological observation, the degree of cell epithelialization in the treatment group was better than that in the control group, which promoted the skin regeneration of the mice in the treatment group significantly faster than that in the control group. By day 7, the skin of mice in the treatment group had basically regenerated completely.
实施例4细胞毒性实验Example 4 Cytotoxicity Experiment
用0.22μm无菌滤膜对实验例2中制备的凝胶进行过滤,除去凝胶中的细菌。将除菌的凝胶用于纤维母细胞毒性实验,作为治疗组;空白作为对照组。The gel prepared in Experimental Example 2 was filtered with a 0.22 μm sterile filter membrane to remove bacteria in the gel. The sterilized gel was used in the fibroblast cytotoxicity experiment as the treatment group; the blank was used as the control group.
本实验采用MTT(3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐)法测定细胞的活力。通过测定凝胶对细胞的毒性,进而评价凝胶的生物相容性。In this experiment, MTT (3-(4,5-dimethylthiazole-2)-2,5-diphenyltetrazolium bromide) method was used to measure cell viability. The biocompatibility of the gel was evaluated by measuring the toxicity of the gel to cells.
(1)用无菌PBS充填96孔板的边缘孔;收集对数期细胞,调整细胞悬浮浓度为50000个/mL,每孔加入100μL细胞悬液。(1) Fill the edge wells of a 96-well plate with sterile PBS; collect logarithmic phase cells, adjust the cell suspension concentration to 50,000 cells/mL, and add 100 μL of cell suspension to each well.
(2)5%CO2,37℃孵育,至细胞单层铺满孔底,加入10μL 5mg/mL凝胶。(2) 5% CO 2 , incubate at 37°C until the cell monolayer covers the bottom of the well, then add 10 μL of 5 mg/mL gel.
(3)细胞放入培养箱,在5%CO2,37℃孵育24h,倒置显微镜下观察。(3) The cells were placed in an incubator, incubated at 37° C. for 24 hours in 5% CO 2 , and observed under an inverted microscope.
(4)每孔加入20μL 5mg/mL MTT,继续培养4h。(4) Add 20 μL of 5 mg/mL MTT to each well, and continue culturing for 4 h.
(5)终止培养,吸去孔内培养液;每孔加入150μL二甲基亚砜,摇床低速振荡10分钟,之后用酶标仪检测OD490nm各孔的吸光值。(5) Terminate the culture, suck off the culture medium in the wells; add 150 μL dimethyl sulfoxide to each well, shake the shaker at low speed for 10 minutes, and then use a microplate reader to detect the absorbance value of each well at OD490nm.
(6)同时设置调零孔(培养基、MTT、二甲基亚砜),对照孔(细胞、同浓度的凝胶、培养基、MTT、二甲基亚砜)。(6) At the same time, set the zero adjustment well (medium, MTT, dimethyl sulfoxide) and the control well (cells, gel with the same concentration, medium, MTT, dimethyl sulfoxide).
(7)计算细胞存活率(cell viability):(7) Calculation of cell viability:
细胞存活率=(凝胶组A值-调零孔A值)/(对照孔A值-调零孔A值)×100%Cell survival rate=(A value of gel group-A value of zero-adjusted well)/(A value of control well-A value of zero-adjusted well)×100%
如图6所示,用纤维母细胞进行细胞毒性实验。实验结果显示:对照组和治疗组的细胞存活率都接近于100%。这说明凝胶敷料对纤维母细胞的毒性非常小,也就是说明凝胶敷料的生物相容性好。As shown in Figure 6, the cytotoxicity experiments were performed with fibroblasts. Experimental results show that: the cell survival rates of both the control group and the treatment group are close to 100%. This shows that the gel dressing has very little toxicity to fibroblasts, which means that the gel dressing has good biocompatibility.
如上所述仅为本发明的几个具体实施例,并不用于限制本发明。凡在本发明的精神和原则之内,采用与其相同或相似方法所得到的基于G-四联体/胶原蛋白的凝胶敷料用于伤口愈合,均在本发明保护范围内。The foregoing are only a few specific embodiments of the present invention, and are not intended to limit the present invention. Within the spirit and principle of the present invention, the use of G-quadruplex/collagen-based gel dressing obtained by the same or similar method for wound healing is within the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611038109.XA CN106620815B (en) | 2016-11-10 | 2016-11-10 | G-quadruplex/collagen based gel dressing and its preparation and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611038109.XA CN106620815B (en) | 2016-11-10 | 2016-11-10 | G-quadruplex/collagen based gel dressing and its preparation and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106620815A true CN106620815A (en) | 2017-05-10 |
| CN106620815B CN106620815B (en) | 2019-07-26 |
Family
ID=58812695
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611038109.XA Active CN106620815B (en) | 2016-11-10 | 2016-11-10 | G-quadruplex/collagen based gel dressing and its preparation and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106620815B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107099004A (en) * | 2017-06-02 | 2017-08-29 | 河南理工大学 | A kind of fluorescence hydrogel of high intensity and preparation method thereof |
| CN113058076A (en) * | 2021-03-29 | 2021-07-02 | 四川大学 | A kind of supramolecular nucleoside hydrogel and preparation method and use thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079342A2 (en) * | 2000-04-18 | 2001-10-25 | Colbar R & D Ltd. | Cross-linked collagen matrices and methods for their preparation |
| CN101391115A (en) * | 2008-11-12 | 2009-03-25 | 乐普(北京)医疗器械股份有限公司 | A kind of preparation method of bioactive protein or polypeptide coating bioscaffold |
| CN103403158A (en) * | 2011-08-11 | 2013-11-20 | 松下电器产业株式会社 | Method for detecting G-quadruplex formation |
| CN104297429A (en) * | 2014-10-15 | 2015-01-21 | 广州甘蔗糖业研究所 | Monosaccharide sensitive type hydrogel and preparation method thereof |
| WO2015073360A2 (en) * | 2013-11-12 | 2015-05-21 | New England Biolabs Inc. | Dnmt inhibitors |
-
2016
- 2016-11-10 CN CN201611038109.XA patent/CN106620815B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001079342A2 (en) * | 2000-04-18 | 2001-10-25 | Colbar R & D Ltd. | Cross-linked collagen matrices and methods for their preparation |
| CN101391115A (en) * | 2008-11-12 | 2009-03-25 | 乐普(北京)医疗器械股份有限公司 | A kind of preparation method of bioactive protein or polypeptide coating bioscaffold |
| CN103403158A (en) * | 2011-08-11 | 2013-11-20 | 松下电器产业株式会社 | Method for detecting G-quadruplex formation |
| WO2015073360A2 (en) * | 2013-11-12 | 2015-05-21 | New England Biolabs Inc. | Dnmt inhibitors |
| CN104297429A (en) * | 2014-10-15 | 2015-01-21 | 广州甘蔗糖业研究所 | Monosaccharide sensitive type hydrogel and preparation method thereof |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107099004A (en) * | 2017-06-02 | 2017-08-29 | 河南理工大学 | A kind of fluorescence hydrogel of high intensity and preparation method thereof |
| CN107099004B (en) * | 2017-06-02 | 2019-08-16 | 河南理工大学 | A kind of fluorescence hydrogel of high intensity and preparation method thereof |
| CN113058076A (en) * | 2021-03-29 | 2021-07-02 | 四川大学 | A kind of supramolecular nucleoside hydrogel and preparation method and use thereof |
| CN113058076B (en) * | 2021-03-29 | 2022-03-11 | 四川大学 | A kind of supramolecular nucleoside hydrogel and preparation method and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106620815B (en) | 2019-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xue et al. | Bioinspired multifunctional biomaterials with hierarchical microstructure for wound dressing | |
| Wu et al. | Incorporation of bioglass improved the mechanical stability and bioactivity of alginate/carboxymethyl chitosan hydrogel wound dressing | |
| WO2019091150A1 (en) | Alginate wound repair dressing and preparation method thereof | |
| Qi et al. | Amoxicillin-laded sodium alginate/cellulose nanocrystals/polyvinyl alcohol composite nanonetwork sponges with enhanced wound healing and antibacterial performance | |
| Jin et al. | Multifunctional self-healing peptide hydrogel for wound healing | |
| CN102657893A (en) | Medical nano-fiber sponge material and preparation method and application thereof | |
| CN103877617A (en) | Injectable silk fibroin-alginate double cross-linking hydrogel and preparation method and use method thereof | |
| CN101773688A (en) | Preparation method of tissue engineering skin containing appendant organs | |
| CN102743796B (en) | Silk fibroin porous support made from polyvinyl alcohol, and preparation method and application thereof | |
| CN103316376A (en) | Endellite composite chitosan haemostasis and wound restoration sponge material, preparation and applications | |
| JP7543311B2 (en) | Novel polysaccharide-based hydrogel scaffolds for wound healing | |
| Indrakumar et al. | Silk Fibroin and Its Nanocomposites for Wound Care: A Comprehensive Review | |
| CN112891615A (en) | Liquid adhesive bandage and preparation method thereof | |
| CN106620815B (en) | G-quadruplex/collagen based gel dressing and its preparation and application | |
| CN110623792B (en) | Medical dressing and preparation method thereof | |
| CN102172337B (en) | Tissue-engineered skin with sebaceous gland-like structure and preparation method thereof | |
| TW201910509A (en) | Macrophage conditioned cultivation medium, dressing, preparation method and use thereof for promoting wound healing capable of promoting fibroblast proliferation and new blood vessel formation | |
| Roy et al. | Stimulated Full-Thickness Cutaneous Wound Healing with Bioactive Dressings of Zinc and Cobalt Ion-Doped Bioactive Glass-Coated Eggshell Membranes in a Diabetic Rabbit Model | |
| CN103656618B (en) | The treatment polypeptide nano fiber gel preparation of skin wound, preparation method and application | |
| Zhu et al. | Effectiveness of nano bioactive glass fiber loaded with platelet-rich plasma on thermal wound healing process in rats | |
| Miguez-Pacheco et al. | Bioactive glasses for soft tissue engineering applications | |
| CN119303154A (en) | A novel keratin-based double-network hydrogel dressing and its preparation method and application | |
| CN114949329B (en) | Preparation method of surface modified silk fibroin-aloin double-layer fiber membrane | |
| CN105999368A (en) | Epidermal growth factor compound wet wound dressing and preparation method thereof | |
| CN101314058A (en) | Modification method for animal skin collagen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CP02 | Change in the address of a patent holder | ||
| CP02 | Change in the address of a patent holder |
Address after: 200241 No. 500, Dongchuan Road, Shanghai, Minhang District Patentee after: EAST CHINA NORMAL University Address before: 200062 No. 3663, Putuo District, Shanghai, Zhongshan North Road Patentee before: EAST CHINA NORMAL University |
|
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20250711 Address after: 201203 Shanghai Pudong New Area, China (Shanghai) Pilot Free Trade Zone, Room 810, 8th Floor, No. 780 Cailun Road Patentee after: Park Heng Bomai (Shanghai) Biopharmaceutical Co.,Ltd. Country or region after: China Address before: 200241 Dongchuan Road, Shanghai, No. 500, No. Patentee before: EAST CHINA NORMAL University Country or region before: China |